Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2005
11/30/2005CN1229179C Method of separating imide compound
11/29/2005US6969729 An indole or benz(g)indole-2,3-dione-3-oxime compounds; therapeutic treatment of respiratory disorders, urogenital disorders, cardiovascular disorders, brain and psychological disorders, gastrointestinal disorders
11/24/2005WO2005111042A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110986A1 Hydroformylation process for pharmaceutical intermediate
11/24/2005WO2005110985A2 Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005110984A1 Process for producing cyclic n-hydroxyimide compound
11/24/2005WO2005110977A1 Substituted cyclohexylcarboxylic acid derivatives
11/24/2005WO2005110976A1 Substituted cyclohexylacetic acid derivatives
11/24/2005WO2005110974A1 Substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005109987A2 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
11/24/2005WO2005090296A3 N-substituted benzene sulfonamides
11/24/2005WO2005073213A3 Method for the production of 3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol derivatives
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261358 Cyclohexylurea compounds
11/24/2005US20050261357 Brain dysfunction or neuropathy caused by loss or degeneration of the neuron; differentiation of a stem cell; 14-(5-methoxy-1H-indole-2-yl)-tetradecane-1-ol
11/24/2005US20050261356 Methods and compositions for the treatment of chronic lymphocytic leukemia
11/24/2005US20050261355 Carvedilol hydobromide
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261244 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050261203 Azabicyclo-octane inhibitors of IAP
11/24/2005CA2565514A1 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1597254A1 Indole-derivative modulators of steroid hormone nuclear receptors
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1597230A1 Novel crystalline forms of trandolapril
11/23/2005EP1503754B1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005EP1320522B1 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP0938474B1 Cyclopropylindole compounds and their use as prodrugs
11/23/2005CN1699342A New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
11/23/2005CN1699341A Process for synthesizing bis-indolyl alkyl compounds
11/23/2005CN1698601A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/23/2005CN1228325C Biguanide derivatives
11/23/2005CN1228292C Blue light emitting compound and electroluminescent device with it as color display substance
11/22/2005US6967200 Remedies for cirrhosis
11/22/2005US6967199 Substituted diamine derivatives useful as motilin antagonists
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108594A1 Enzymatic ammonolysis process for the preparation of intermediates for dpp iv inhibitors
11/17/2005WO2005108391A1 Amides as bace inhibitors
11/17/2005WO2005108390A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108368A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005WO2005108366A1 A process for the preparation of 2-[n-­ [(s)-1-ethoxycarbonyl-3-phenylpropyl]-(s)-alanyl]-(1s, 3s, 5s) -2-azabicyclo [3.3.0] octane-3­-carboxylic acid
11/17/2005WO2005108365A1 Processes for the preparation of alpha polymorph of perindopril erbumine
11/17/2005WO2005108364A1 Piperazine derivatives of alkyl oxindoles
11/17/2005WO2005108363A1 Piperazine derivatives of alkyl oxindoles
11/17/2005WO2005108362A1 (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease
11/17/2005WO2005108358A2 Pyrrolidine derivatives useful as bace inhibitors
11/17/2005WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof
11/17/2005US20050256316 Preparation of phosphatase inhibitors
11/17/2005US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256132 Use of ER selective NF-kB inhibitors for the treatment of sepsis
11/17/2005US20050256117 Ophthalmic compositions for treating ocular hypertension
11/17/2005US20050256106 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
11/17/2005US20050256031 Composition for relieving discomfort
11/17/2005US20050256019 contacting 2S)-2-aminocarbonyl-2,3-dihydro-1H-pyrrole-1-carboxylic acid, 1-(1,1-dimethylethyl) ester with an enzyme which is a fraction of B lipase from yeast candida antarctica, to catalyze the ammonolysis of above compound in presence of ammonium carbamate and/or ammonia
11/17/2005US20050255391 Polymerisable diketopyrrolopyrroles, use of such compounds in colour filters and polymers prepared from these compounds
11/17/2005CA2568241A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11/17/2005CA2566426A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/17/2005CA2566096A1 Piperazine derivatives of alkyl oxindoles
11/17/2005CA2565214A1 (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease
11/17/2005CA2564009A1 Piperazine derivatives of alkyl oxindoles
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005EP1594857A2 N-monoacylated o-phenylenediamines as anti-cancer agents
11/16/2005EP1594856A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
11/16/2005EP1594493A2 Polymorphic forms of tegaserod base and salts thereof
11/16/2005EP1487796A4 Substituted biaryl amides as c5a receptor modulators
11/16/2005EP1421634B1 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/16/2005EP1397129B1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
11/16/2005EP0944583B1 Novel compounds useful as therapeutic agents and assay reagents
11/16/2005EP0834074B2 Detection of transmembrane potentials by optical methods
11/16/2005CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/16/2005CN1227008C Method of converting COX-2 inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
11/15/2005US6965037 Method for producing aminocarbazoles
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964980 Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
11/15/2005US6964977 E.g., 5-(((Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-amino)-1,3-dihydro-2H -benzimidazol-2-one; inhibition or antagonism of protein kinases; treating pain or cancer
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them
11/15/2005CA2296637C Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containingit
11/10/2005WO2005105828A1 Pseudopeptides growth hormone secretagogues
11/10/2005WO2005105791A1 Indolyl derivatives as liver-x-receptor modulators
11/10/2005WO2005105785A2 Indole derivatives for treatment of obesity
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105741A1 Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
11/10/2005WO2005105740A2 Preparation of tegaserod and tegaserod maleate
11/10/2005WO2005087721A3 Compounds as inhibitors of hepatitis c virus ns3 serine protease
11/10/2005WO2004113292B1 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 458